In an innovative study released in October 2024, a group headed by Yamasaki investigated how retinal organoids derived from human pluripotent stem cells could be used to treat macular holes in a non-human primate model. This study marks progress in the creation of regenerative treatments for challenging macular holes, which cannot be fully corrected through standard surgery.
Macular Hole and Challenges in Treatment
A macular hole is a tear in the retina’s center resulting in vision issues. This problem commonly seen in adults can be caused by traction on the retina. One of the treatments involves a surgical procedure known as pars plana vitrectomy. During which the membrane inside the eye is removed and gas is used to assist in healing. While this method is successful in closing more than 90% of macular holes some cases especially those involving individuals with conditions like high myopia or large holes can pose challenges. A recently developed technique called autologous retinal transplantation has shown promise in restoring retinal structure in many cases. However it does come with risks such as causing blind spots in the area where tissue is extracted for the graft.
Study Overview
Yamasaki’s team conducted a study where they implanted retinal sheets made from human embryonic stem cells (hESCs) into the macular holes (MHs) of Japanese macaques. This method provided a new approach for regeneration. The research involved utilizing sheets that imitate early retinal tissue to replace the damaged tissue within the macular hole. The main goal of the study was to assess the ability of the transplanted cells to seal the MHs develop into fully working photoreceptors and improve eyesight.
Results of Transplantation
Following the surgery, the sheet successfully covered the hole in the membrane showing positive signs of tissue integration. The transplanted retinal tissue known as photoreceptors which are cells essential for perceiving light matured into rod and cone cells. Although the researchers could not confirm direct connections between the host retina and the transplanted tissue visual function improved in the primates that were treated.
Electrophysiological tests, specifically, electroretinograms (ERG), revealed increased responses in the foveal area of the transplanted eye suggesting some degree of recovery. The study also observed enhancements in tests for visual fixation. These findings indicate that transplantation has the potential to aid in healing the retina and play a role in restoring vision for individuals with challenging cases of membrane.
Managing Immune Response and Graft Rejection
During this study which included transplanting tissue across species. The researchers were prepared for the possibility of rejection. At four months post surgery, some signs of rejection were observed such as retinal swelling and inflammation. However these symptoms were managed using steroid injections. After six months the immune response had decreased and the transplant seemed to be stable without causing any additional inflammation.
Implications and Future Directions
This study emphasizes, the possibility of using retina organoids obtained from human embryonic stem cells, to treat macular holes offering advantages over assisted reproduction technology methods. In contrast to the situationally, this approach eliminates the requirement to extract retinal tissue from the edge of the patients retina thereby preserving their visual fields. Furthermore the organ transplants from human embryonic stem cells primarily consisted of precursor cells that could potentially improve their fusion with the retina.
However there are challenges to address. Despite progress in restoring vision, the lack of established connections between the transplant and the recipient’s retina poses a hurdle to fully reinstating visual functions. Future research endeavors will need to focus on encouraging the development of connections between the host cells and the transplant as well as enhancing immune tolerance to boost the viability of implementing this treatment in a clinical setting.
To summarize this research represents a significant advancement in the field of regenerative medicine showcasing how utilizing retinal transplants from stem cells holds promise in healing macular holes and enhancing vision in primates. Further studies have the potential to translate these discoveries into therapies for individuals coping with retinal conditions that jeopardize their eyesight.
Source: